← Back to news
Y

Yahoo Finance

Bank of America Asserts Buy Rating on Coinbase Global Inc. (COIN) Buoyed by Growth Opportunities

Y

5 assets you’ll almost never regret buying in retirement (if you crave both income and security)

Y

Oil Steady as Trump Threatens Greenland While Iran Tensions Wane

Y

Wall Street Firms Tout Robinhood Markets, Inc. (HOOD) Prospects amid Prediction Market Opportunity

Y

Mixed Strategic Drivers Led Upslope Capital Management to Pick Henry Schein (HSIC)

Y

Crypto Investments Hit Record Highs: $2.17 Billion Inflows Signal Bullish Revival, but Tariff Clouds Loom

Y

Here’s the Minimum Net Worth Considered To Be Upper Middle Class at 50

Y

Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities

Y

Will Booz Allen Hamilton (BAH) Benefit from Long-Term Secular Tailwinds?

Y

Dollar dented as Trump tariff threats drive investors into safe havens

Y

Is Robinhood Stock a Millionaire Maker?

Y

Here’s What the Wall Street Thinks About WeRide Inc (WRD)

Y

J.P. Morgan Downgrades Melco Resorts & Entertainment (MLCO) To Hold

Y

Bitfarms Ltd. (BITF) Announces the Sale of Bitcoin Mining Site in Paso Pe

Y

MannKind Corporation (MNKD) Reveals 2026 Growth Drivers

Y

Autopaying Bills: What Are the Pros and Cons of Using Credit vs. Debit?

Y

Northland Initiates CleanSpark (CLSK) at Outperform with $22.50 PT on Strategic AI Pivot

Y

Webull Corporation (BULL) Partners With Level2

Y

KeyBanc Adjusts Rubrik (RBRK) PT to $95 Citing Valuation Multiples and Enterprise Spending Caution

Y

Enovix Corporation (ENVX) Confirms Results From Independent Lab For its AI-1 Battery

Y

Goldman Sachs Trims Remitly (RELY) PT to $17 While Keeping Buy Rating on Remittance Growth

Y

Wall Street Bullish on Crescent Energy Company (CRGY)

Y

Here’s What the Wall Street Thinks About Nuvation Bio Inc. (NUVB)

Y

Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders

Y

Wall Street is Bullish on BGC Group (BGC)

Y

Canaccord Hikes Intuitive Machines (LUNR) PT to $22.50 as 2026 Space Landscape Brightens

Y

TD Cowen Trims Sezzle (SEZL) PT to $82 Amid Macro Pressures and Shifting Specialty Finance Outlook

Y

Here’s What the Wall Street Thinks About Payoneer Global (PAYO)

Y

Morgan Stanley Backs Tenaya Therapeutics (TNYA) as SMID-Cap Biotech Primed to Outperform in 2026

Y

Raymond James Cautions on EverCommerce (EVCM) Growth as Insider Ownership and Liquidity Headwinds Loom

Y

Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target

Y

H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue

Y

Occidental Petroleum’s Quarterly Earnings Preview: What You Need to Know

Y

McDonald’s answers a major question for MLK Day 2026

Y

Hedge Fund Picton Says Markets Will Punish a Fed That Bows to Trump

Y

Here's What to Expect From LKQ Corporation's Next Earnings Report

Y

3 Underrated Tips For Paying Off Debt In 2026, According to Experts

Y

Alibaba Stock Drops After a Blistering AI Rally. These 2 Worries Are Rattling Investors.

Y

Europe’s auto supplier industry faces big job losses – CLEPA

Y

What Drove Gold and Silver to Record Highs This Weekend?

Y

Amazon’s New Sovereign Cloud Solidifies its Long-Term Growth Potential

Y

Citi Bullish on Broadcom (AVGO) as Accelerating AI Sales Drive $480 PT

Y

Baird Raises JPMorgan (JPM) PT to $280 Following Strong Q4 Results, Robust Credit Quality

Y

Citi Maintains Neutral on AMD With $260 PT as Muted Margin Leverage Tempers AI Growth

Y

Wells Fargo Downgrades Intuit (INTU) as “Impossible” 2025 Comparisons Cloud 2026 Growth Outlook

Y

Morgan Stanley Raises S&P Global (SPGI) PT to $627 on Robust Year-End Debt Issuance Surge

Y

Goldman Sachs Initiates Workday (WDAY) at Neutral as Challenging Market Share Gains Temper AI Optimism

Y

Bernstein Names Vertex (VRTX) a “Top Biotech Pick” for 2026 Following Upgrade to Outperform

Y

Northcoast Upgrades Axon (AXON) to Buy With $742 Price Target

Y

AstraZeneca’s Subcutaneous Saphnelo Shows Significant Disease Reduction in Landmark Lupus Trial

Y